|
COGT Cogent Biosciences Inc 1622229 |
| Balance Sheet |
|
Current Assets
|
296,472,000 |
|
Assets
|
327,898,000 |
|
Current Liabilities
|
55,710,000 |
|
Liabilities
|
71,612,000 |
|
Equity
|
256,286,000 |
|
Shares Out
|
109,450,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-207,791,000 |
|
Investing Cash Flow
|
38,276,000 |
| Market Analysis |
Market Cap
|
1,149,229,200 |
|
Price
|
7.34 |
|
BVPS
|
2.34 |
|
PB
|
3.14 |
|
EPS
|
-2.48 |
|
PS
|
3.34 |
|
FCF
|
-169,515,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view COGT documents filed with the SEC.
COGT Filings
Clear
